by TractManager | Aug 23, 2024 | Emerging Technology Report
Midomafetamine (MDMA; also 3,4-methylenedioxymethamphetamine; Lykos Therapeutics) is an oral synthetic entactogen under investigation in combination with psychological intervention for the treatment of adults with posttraumatic stress disorder (PTSD).
by TractManager | Aug 20, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Evoque Tricuspid Valve Replacement System (Edwards Lifesciences Corp.) to treat patients with severe (or...
by TractManager | Aug 20, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of capsular plication for treatment of hip microinstability.
by TractManager | Aug 20, 2024 | Emerging Technology Report
Nemolizumab-ilto (Nemluvio; Galderma) is a subcutaneously injected interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.
by TractManager | Aug 15, 2024 | Emerging Technology Report
AB-1002 (Bayer AG) is an investigational one-time gene therapy administered via intracoronary artery infusion to reduce symptoms of advanced nonischemic heart failure.
Recent Comments